Introduction
============

*Klebsiella* *pneumoniae* is a Gram-negative pathogen, which causes purulent abscess, bacteremia, and urinary as well as respiratory tract infections mostly in patients with underlying diseases ([@B49]). Similar to many enteric bacteria, *K. pneumoniae* needs to sense various environmental signals, including temperature, nutrition-limitation, pH, oxygen availability, osmolality, as well as other stimuli, in order to achieve successful infection ([@B10]; [@B38]). Bacterial two-component systems (TCSs), typically consisting of a sensor histidine kinase and a response regulator, play a crucial role in sensing environmental signals and subsequent regulation of gene expression at the transcriptional level ([@B61]; [@B30]). In Gram-negative bacteria, the OmpR/EnvZ TCS can sense an osmotic signal to further control downstream gene expression including genes encoding outer membrane proteins and various virulence factors ([@B41]; [@B46]). EnvZ, the sensor kinase, auto-phosphorylates a conserved histidine residue in response to extracellular osmolality and then transfers the phosphate group to aspartate residue 55 on the receiver domain of OmpR to exert DNA binding activity ([@B66]; [@B21]; [@B13]). In uropathogenic *Escherichia coli*, OmpR promotes bacterial survival in the murine urinary tract and growth in human urine ([@B57]). In addition, deletion of *ompR* can increase type 1 fimbriae expression via activation of *fimB* transcription and phase-ON positioning of the *fimS* element under a high osmolality environment ([@B53]). In *E. coli*, OmpR increases biofilm amount by negatively regulating the expression of a flagellar regulator ([@B54]). Likewise, *Yersinia enterocolitica* OmpR promotes biofilm formation, but positively regulates flagellar synthesis ([@B51]). Furthermore, the important role of OmpR in the control of bacterial virulence has been demonstrated in many bacteria including *Salmonella* Typhimurium, *Shigella flexneri*, *Y. pestis*, and *Acinetobacter baumannii* ([@B15]; [@B6]; [@B52]; [@B67]). However, the role of OmpR in *K. pneumoniae* pathogenesis remains unknown.

Multiple virulence factors have been shown to be involved in *K. pneumoniae* infection including capsular polysaccharide (), lipopolysaccharides (LPS), type 1 and type 3 fimbriae, iron-acquisition systems, porins, and antibiotic resistance determinants, e.g., carbapenemases, extended-spectrum β-lactamases, efflux systems, DNA gyrase, and topoisomerase IV ([@B47]; [@B31]). However, most of these virulence factors are processed or embedded in the cell envelope and enable bacteria to take up nutrients and adhere to diverse surfaces or niches within the human host ([@B72]; [@B26]). In addition, biofilm formation is considered a key factor in the development of nosocomial infections and increases bacterial resistance to antibiotics, thus hindering medical treatment ([@B44]). CPS, LPS, and fimbriae are involved in biofilm formation in *K. pneumoniae* ([@B56]; [@B4]). Interestingly, the thick capsule of *K. pneumoniae* inhibits fimbriae activity and assembly ([@B56]) and cross-regulated expression between fimbriae and CPS for efficient infection has been suggested. Of these factors, type 3 fimbriae are considered the major determinant of biofilm formation in *K. pneumoniae* ([@B14]; [@B22]; [@B71]). Although most *K. pneumoniae* strains possess type 1 and 3 fimbriae, type 3 fimbriae are mainly expressed in heavily encapsulated *K. pneumoniae* strains, while the production of type 1 fimbriae is poor and phase-variable ([@B56]; [@B62]). Therefore, elucidating the regulation of type 3 fimbriae is required to gain a deeper understanding of *K. pneumoniae* pathogenesis.

In *K. pneumoniae*, type 3 fimbriae are encoded by the *mrkABCDF* operon ([@B14]; [@B22]; [@B71]). A cyclic di-GMP (c-di-GMP) related gene cluster, *mrkHIJ*, located downstream of the type 3 fimbrial genes, has been demonstrated to play a central role in regulating type 3 fimbriae expression ([@B70]; [@B44]; [@B71]; [@B74]). Reverse-transcription PCR analysis revealed that while *mrkHIJ* is transcribed as a polycistronic mRNA, *mrkJ* is also independently transcribed ([@B71]). MrkH possesses that a PilZ-domain that binds c-di-GMP to activate its own promoter activity and type 3 fimbriae expression ([@B70]; [@B74]; [@B65]). MrkI is a predicated LuxR-type transcriptional regulator to activate its own operon and type 3 fimbriae expression ([@B71]). MrkJ contains an EAL domain with functional c-di-GMP phosphodiesterase (PDE) activity for hydrolysis of c-di-GMP and further repression of type 3 fimbriae expression ([@B24]). Although MrkHIJ play a critical role in regulating type 3 fimbriae expression, the regulation of *mrkHIJ* remains unclear. c-di-GMP is a bacterial secondary messenger that modulates biofilm formation and the expression of various virulence factors ([@B64]; [@B23]). The intracellular concentration of c-di-GMP in bacteria is modulated by di-guanylate cyclases (DGCs) and PDEs ([@B58]; [@B19]). *K. pneumoniae* YfiN harbors DGC domain and has a positive role in the control of type 3 fimbriae expression ([@B70]), while YjcC possess a PDE domain and plays a negative role in type 3 fimbriae expression ([@B20]). In addition to c-di-GMP-related proteins, several transcriptional regulators have been reported to be involved in the control of type 3 fimbriae expression in *K. pneumoniae* including histone-like nucleoid-structuring protein (H-NS), CRP, and ferric uptake regulator (Fur) ([@B71]; [@B3]; [@B36]). Thus, the regulation of type 3 fimbriae in *K. pneumoniae* in response to different environmental stimuli is complicated.

In this study, we found that type 3 fimbriae expression in *K. pneumoniae* was decreased under hypertonic conditions. In addition, phosphorylated OmpR (OmpR∼P) activated type 3 fimbriae expression through the c-di-GMP signaling pathway and further affected biofilm amount in response to osmolality stresses.

Materials and Methods {#s1}
=====================

All chemicals and reagents were purchased from Sigma (St. Louis, MO, United States) unless otherwise stated. All enzymes were purchased from New England Biolabs unless otherwise stated. General molecular techniques, e.g., PCR and eletroporation, were performed according to standard protocols ([@B55]).

Bacterial Strains, Plasmids, and Culture Conditions
---------------------------------------------------

All bacterial strains and plasmids used in this study are listed in **Table [1](#T1){ref-type="table"}**. Primers used in this study are listed in **Table [2](#T2){ref-type="table"}**. Each strain was grown overnight in Luria-Bertani (LB) medium (1% tryptone, 0.5% yeast extract, and 1% \[∼170 mM\] sodium chloride \[NaCl\]) (BD Difco^TM^) with respective antibiotics at 37°C for 16 h, and then 1/200 of overnight culture were inoculated into LB broth at concentrations of 0, 50, 200, or 400 mM of NaCl until the bacteria were grown after that to reach exponential phase (OD~600nm~ = 0.6--0.8). However, instead of 1% NaCl, we used LB medium supplemented with 2.32% NaCl (= 400 mM) to analyze the hypertonic effects in *K. pneumoniae*. The antibiotics used include ampicillin (100 μg/ml), kanamycin (25 μg/ml), streptomycin (500 μg/ml), and tetracycline (12.5 μg/ml).

###### 

Bacterial strains and plasmids used in this study.

  Strains or plasmids   Descriptions                                                                          Reference or source
  --------------------- ------------------------------------------------------------------------------------- ---------------------
  ***K. pneumoniae***                                                                                         
  CG43S3                CG43 Sm^r^                                                                            [@B28]
  Δ*ompR*               CG43S3Δ*ompR*                                                                         This study
  *ompR~D55A~*          CG43S3*ompR~D55A~*                                                                    This study
  Δ*lacZ*               CG43S3Δ*lacZ*                                                                         [@B35]
  Δ*lacZ-*Δ*ompR*       CG43S3Δ*lacZ*Δ*ompR*                                                                  This study
  Δ*lacZ- ompR~D55A~*   CG43S3Δ*lacZompR~D55A~*                                                               This study
  ***E. coli***                                                                                               
  BL21(DE3)             *F^-^ ompT hsdS~B~\[r~B~^-^m~B~^-^\]gal dcm* \[DE3\]                                  New England Biolabs
  S17-1 *λ pir*         *hsdR recA pro* RP4-2 \[Tc::Mu; Km::Tn*7*\] \[*λpir*\]                                [@B40]
  **Plasmids**                                                                                                
  yT&A                  Ap^R^, TA PCR cloning vector                                                          Yeastern
  pKAS46                Ap^r^, Km^r^, Positive selection suicide vector, *rpsL*                               [@B59]
  pACYC184              Cm^r^, Tc^r^, plasmid with *p15A* origin of replication                               [@B11]
  pmrkAZ15              Cm^r^, 402 bp fragment containing the region upstream of *mrkA* cloned into placZ15   [@B36]
  pompR                 Cm^r^, 1079 bp fragment containing an *ompR* allele cloned into pACYC184              This study
  pET30b-OmpR           Km^r^, 716 bp fragment encoding full-length *ompR* allele cloned into pET30b          This study

###### 

Primers used in this study.

  Primer            Sequence (5′ → 3′)              Enzyme cleaved      
  ----------------- ------------------------------- ------------------- ------------
  GT254             GGGATCCAGACCGTCTGGGGTCT         *Bam*HI             
  GT255             CTCTAGACAGCGGGTGCATACG          *Xba*I              
  GT256             CGGATCCATCTGTTCGGCGTTC          *Bam*HI             
  GT257             CGAGCTCTACCTGTTCGGCTCTGGC       *Sac*I              
  GT284             GGGATCCGCTCTCCATCAATGCTAA       *Bam*HI             
  GT285             GAGATCTGAAAGACGTAGCGTACAGC      *Bgl*II             
  GT288             CGGATCCAGACAAAATGGAGGGAACCCTA   *Bam*HI             
  GT290             GCAATAGCAACATTCTGATTGG                              
  GT336             CCATATGCAAGAGAATTATAAGATTCT     *Nde*I              
  GT337             GAAGCTTGCCTTAGAACCGTCCGGGAC     *Hind*III           
  GT356             ATGCTGCCGGGCGAAGATGGT                               
  GT357             TTCTAGATACGAATAAACAGCCA         *Xba*I              
  GT363             CAGAGCCAGCACCATCAGGTGGA                             
  GT367             GACATCAATCTGAAAGGCCAG                               
  GT368             AGGGATCACCACTGCCAGAA                                
  CC323             GGATCCTGCATGCTGTTGCGGTCAC       *Bam*HI             
  CC324             GGATCCGCGGTTGCCATTGCTGCAGAG     *Bam*HI             
  SY01              GGGATCCGGTAGTCCATCTCCTGCTTCA    *Bam*HI             
  SY02              GAAGCTTGACGAACAGCAAGGTGACG      *Hind*III           
                                                                        
  **For qRT-PCR**   **Sequence (5′ → 3′)**          **TaqMan probes**   **Target**
                                                                        
  RT11              GGTAGGGGAGCGTTCTGTAA            67                  23S rRNA
  RT12              TCAGCATTCGCACTTCTGAT                                
  RT29              TAAGCAAACTGGGCGTGAA             20                  *mrkA*
  RT30              TAGCCCTGTTGTTTGCTGGT                                
  GT46              GTTTAAGTTCCGCCATCTCG            120                 *mrkH*
  GT47              TTGCGCTTGGCTTCTAAGAT                                
  GT42              AGTTATGCCGATGTCATCCAT           59                  *mrkI*
  GT43              GATTCTGATGGCAGAAATATCCTT                            
  GT54              TTTCGAGGTAACCGAAAACG            84                  *mrkJ*
  GT55              GAGGTATCCTGTGGGCTCTG                                
  RT159             CTGGCTGGATGATTTTGGTC            67                  D364_06025
  RT160             CCACTTTGACGCAATCGAA                                 
  RT161             CGTAGGCTGGCTGATGGA              40                  D364_08130
  RT162             TCTGTCTCGGTGACCTCGAT                                
  RT164             GGGTTTGCTGATATCGATGG            67                  D364_13295
  RT165             AGCCAACGTTTTGACATGCT                                
  RT169             ATCGATTTTCGCCATCAGAG            70                  *fimK*
  RT170             GAAAAGCAGTCGTCCAGCAT                                
  RT175             AATGGTCATCCGGGAAGC              20                  *yjcC*
  RT176             CCGCTGAACACAACTCACC                                 
  RT244             GCATCGTAACCTGGTCTTCAA           36                  D364_02175
  RT245             GAGCAGGCTGGTGAAAATG                                 
  RT273             CCAGGATCCTCGCCACTAT             22                  D364_04060
  RT274             TCCCGACCTTACCAAAACG                                 
  RT275             CGCCGGTACTGATCCAAT              28                  D364_11845
  RT276             ATTCACCACCAGCATCACG                                 
  RT277             GCTACCTGGTGCGCAATATAA           68                  D364_16830
  RT278             TCGCCATAAATACAGCGTAGC                               

Construction of the *ompR* Deletion Mutant and Its Complementation
------------------------------------------------------------------

A specific *ompR* gene deletion was introduced into *K. pneumoniae* CG43S3 using an allelic exchange strategy as previously described ([@B29]). Briefly, the upstream and downstream regions (approximately 1000 bp DNA fragments) of *ompR* were cloned into suicide vector pKAS46 containing *rpsL*, which allows positive selection for the loss of vector with streptomycin ([@B59]). The resulting plasmid was then mobilized from *E. coli* S17-1λ*pir* ([@B40]) to *K. pneumoniae* CG43S3 or CG43S3-derived strains by conjugation. Overnight cultures of donor and recipient strains were mixed in a ratio of 2:1, and the mixture was washed in saline (0.9% NaCl). An aliquot of 30 μl of the mixture was spotted on an LB plate incubated at 37°C for 24 h and plated on M9 agar plates (6.78 g/L Na~2~HPO~4~, 3 g/L KH~2~PO~4~, 1 g/L NH~4~Cl, 0.5 g/L NaCl, 20% glucose, 1.5% agar) with ampicillin (100 μg/ml) and kanamycin (25 μg/ml) for selection of transconjugants. Several of the ampicillin and kanamycin-resistant transconjugants were picked, grown in LB broth supplemented with 500 μg/ml streptomycin to exponential phase at 37°C, and then spread on LB agar plate containing 500 μg/ml streptomycin. Following the occurrence of a double crossover, streptomycin-resistant and kanamycin-sensitive colonies were selected and the deletion was verified by PCR and Southern hybridization (data not shown).

To obtain the complementation plasmid (pOmpR), a DNA fragment containing the promoter and coding sequence of *ompR* was PCR amplified using primer pair SY01/SY02 (**Table [2](#T2){ref-type="table"}**) and cloned into the pACYC184 shuttle vector ([@B11]). Next, pompR and pACYC184 were transformed into Δ*ompR* strain by electroporation.

Construction of a *K. pneumoniae ompR~D55A~* Mutant
---------------------------------------------------

A DNA fragment carrying *ompR* and approximately 1000 bp adjacent regions on either side was amplified by PCR using primer pairs GT257/GT357 (**Table [2](#T2){ref-type="table"}**) and cloned into yT&A vector (Yeastern). The resulting plasmid was used as the template for the inverse-PCR ([@B45]) with the primer pair GT356/GT363 (**Table [2](#T2){ref-type="table"}**) to generate a mutant *ompR* allele encoding the D55A mutation, which was confirmed by Sanger sequencing (Genomics, Taiwan). Subsequently, the mutant allele of *ompR* was subcloned into pKAS46 ([@B59]) and confirmed by DNA sequencing. Then, the plasmid was mobilized from *E. coli* S17-1 λ*pir* to the *K. pneumoniae* Δ*ompR* strain by conjugation, and the subsequent selection was performed as described above.

Western Blotting
----------------

The total proteins of exponential phase *K. pneumoniae* cultures were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (approximately 5 μg per lane) and transferred to polyvinylidene difluoride membrane. Western analysis was followed as previously described ([@B36]). Rabbit anti-MrkA antibody (customer antibody service from LTK BioLaboratories) and Goat anti-rabbit immunoglobulin G antibody conjugated to horseradish peroxidase (Abcam) were used as the primary antibody and the secondary antibody, respectively. After incubation with the secondary antibody, the signal in the membranes was collected by ImageQuant LAS 4000 mini (GE Health, United States) after the visualization with an enhanced chemiluminescence ECL western blotting luminal reagent (PerkinElmer, Wellesley, MA, United States).

Quantitative Reverse-Transcription PCR (qRT-PCR)
------------------------------------------------

As previous study, total RNA extraction, reverse transcription of isolated mRNA to cDNA, qRT-PCR, and data analysis were performed ([@B34]). Primers and probes for selected target sequences were designed by using Universal ProbeLibrary Assay Design Center (Roche-applied science) and shown in **Table [2](#T2){ref-type="table"}**. Relative gene expressions were quantified using the comparative threshold cycle 2^-ΔΔCT^ method with 23S rRNA as the endogenous reference.

Measurement of Promoter Activity
--------------------------------

To measure the *mrkA* promoter activity, *K. pneumoniae* strains was transformed with the promoter-reporter plasmid pmrkAZ15 into by electroporation, respectively. As previously described ([@B35]), the β-galactosidase activity of logarithmic phase bacteria was measured.

Construction and Purification of OmpR::His~6~
---------------------------------------------

The coding region of *ompR* was PCR amplified with primer sets GT336/GT337 (**Table [2](#T2){ref-type="table"}**) and cloned into the *Nde*I/*Hind*III site in pET30b (Novagen, 205 Madison, Wis). The resulting plasmid pET30b-OmpR was then transformed into *E. coli* BL21(DE3) (New England Biolabs), and overproduction of the recombinant protein was induced by the addition of 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 4 h at 37°C. The recombinant proteins were then purified from the soluble fraction of the total cell lysate by affinity chromatography using His-Bind resin (Novagen, Madison, Wis). Finally, the purified proteins were dialyzed against GMS buffer (50 mM Tris-HCl, pH 7.5, 50 mM KCl, 10 mM MgCl~2~, 0.5 mM EDTA, and 10% glycerol) at 4°C overnight, and the purity was determined by SDS-PAGE.

Electrophoretic Mobility Shift Assay (EMSA)
-------------------------------------------

DNA fragments of the putative promoter region of *mrkA*, *mrkHI*, *mrkJ*, and *ompF* were individually PCR-amplified with primer pairs CC323/CC324, GT288/GT290, GT284/GT285, and GT367/GT368 sets by Pfu-polymerase to generate DNA probes for EMSA. Briefly, the purified OmpR::His~6~ was incubated with 10 ng DNA in a 10 μl solution containing 10 mM Tris-HCl, pH 7.4, 50 mM KCl, 1 mM DTT, 10 mM MgCl~2~, 10% glycerol, and 25 mM acetyl-phosphate at room temperature for 20 min. The samples were then loaded onto a native gel of 5% non-denaturing polyacrylamide in 0.5X TB buffer (45 mM Tris-HCl, pH 8.0, 45 mM boric acid). Gels were electrophoresed with a 20-mA current at 4°C and then stained with SYBR Green I dye (Invitrogen). The assay was repeated in at least 3 independent experiments.

Intracellular Concentration of c-di-GMP
---------------------------------------

The intracellular c-di-GMP in late exponential phase *K. pneumoniae* cultures (OD~600nm~ = 1.0--1.2) was extracted according to the previous study ([@B43]). The dried extracts were solubilized in distill water and further were measured the c-di-GMP level by a ELISA kit (Wuhan EIAab Science Co., Ltd). The c-di-GMP concentration was normalized by total protein concentration. Relative percentage of c-di-GMP content was calculated by the c-di-GMP concentration of extracts is relative to that of wild type (WT) strain.

PDE Activity
------------

The PDE activity of the crude extracts in exponential phase *K. pneumoniae* strains was performed as previous study by using *bis*(*p*-nitrophenyl) phosphate (*bis*-*p*NPP) ([@B24]). Briefly, 10 μg of total protein in assay buffer (50 mM Tris-HCl, 1 mM MnCl~2~ \[pH 8.5\]) supplemented with 5 mM bis-*p*NPP at 37°C for 5 min. The PDE activity was determined by measuring the release of *p*-nitrophenol at OD~410nm~. Relative percentage of PDE activity was calculated by the OD~410nm~ of crude extracts is relative to that of WT strain.

Quantification of Biofilm Amount
--------------------------------

Biofilm amount was assessed by the ability of the cells to adhere to the walls of 96-well microtitre dishes made of PVC (TPP 96 flat) with some modification of the reported protocol ([@B32]). The plate contained an aliquot of 1:10 diluted overnight bacteria culture and then was incubated at 37°C statically for 24 h for biofilm formation. The biofilms were washed triply with 200 μl PBS to remove non-adherent bacteria and then adherent bacteria was stained with 200 μl of 0.1% safranin solution at room temperature for 30 min. The plates was rinsed twice with deionizer water to remove excess stain. Finally, the safranin stained biofilm was solubilized in 200 μl of 95% ethanol and the absorbance determined at OD~492nm~.

Statistical Method
------------------

The results of qRT-PCR analysis, promoter activity, c-di-GMP concentration, PDE activity, and biofilm amount were performed by biological replicates at least triplicate. The results are showed as the mean and standard deviation. Differences between groups were evaluated by an unpaired *t*-test. Values of *P* \< 0.05 and *P* \< 0.01 were considered statistically significant differences.

Results
=======

The Role of OmpR in Regulating MrkA Production Under Hypertonic Conditions
--------------------------------------------------------------------------

To investigate whether the expression of type 3 fimbriae in *K. pneumoniae* is affected by hypertonic conditions, *K. pneumoniae* CG43S3 was grown in LB broth with increasing concentrations of NaCl and the MrkA production, the major subunit of type 3 fimbriae, was determined by western blotting analysis. As shown in **Figure [1A](#F1){ref-type="fig"}**, MrkA production decreased when *K. pneumoniae* was grown in LB broth with 50, 200, and 400 mM NaCl, compared to LB broth without NaCl. This indicates that MrkA production was repressed in response to increasing hypertonic stress. To determine whether OmpR is involved in this regulation, a deletion mutant of *ompR* was generated in *K. pneumoniae* CG43S3. MrkA production similarity decreased in the Δ*ompR* strain in response to NaCl. However, MrkA production was lower in the Δ*ompR* strain than in the WT strain in LB broth without NaCl; in LB broth with 400 mM NaCl, MrkA production was markedly reduced in the Δ*ompR* strain compared to the WT strain. To confirm the effect of *ompR* deletion on MrkA production, the complementation plasmid, pompR, and the empty vector, pACYC184, were introduced into the Δ*ompR* strain and MrkA production was evaluated in LB broth with 400 mM NaCl. As shown in **Figure [1B](#F1){ref-type="fig"}**, MrkA production was higher in the Δ*ompR*\[pompR\] strain than in the Δ*ompR*\[pACYC184\] strain; this confirms that OmpR can increase MrkA production in *K. pneumoniae* CG43S3 in response to hypertonic stresses.

![Hypertonic stress and OmpR affect MrkA production ount in *K. pneumoniae* CG43S3. **(A)** *K. pneumoniae* CG43S3 WT and Δ*ompR* strains were grown overnight at 37°C with agitation in LB broth with or without NaCl as indicated to observe the MrkA production by western blot analysis against MrkA. Likewise, the strains, Δ*ompR* (pACYC184) and Δ*ompR* (pOmpR)~,~ were grown to mid-log phase at 37°C in LB broth with 400 mM NaCl to observe the MrkA production **(B)**. The fold change of MrkA production calculated by Image J software is also shown.](fmicb-09-02405-g001){#F1}

OmpR Increases *mrkA* Expression at the Transcriptional Level
-------------------------------------------------------------

To analyze the regulatory role of OmpR in type 3 fimbriae expression in response to hypertonic stimulus, the effect of *ompR* deletion on *mrkA* mRNA levels was measured in the WT and Δ*ompR* strains grown in LB broth with or without 400 mM NaCl using qRT-PCR. As shown in **Figure [2A](#F2){ref-type="fig"}**, *mrkA* mRNA levels were lower in the ΔtextitompR strain than in the WT strain in LB broth with 400 mM NaCl, while no apparent effect was observed in LB without NaCl. In addition, introduction of the complementation plasmid pompR into Δ*ompR* reversed the effect of the deletion in response to 400 mM NaCl. To further investigate whether OmpR affects the promoter activity of *mrkA*, a plasmid carrying P*~mrkA~* fused to a *lacZ* reporter gene was introduced into the Δ*lacZ* and Δ*lacZ*Δ*ompR* strains. As shown in **Figure [2B](#F2){ref-type="fig"}**, P*~mrkA~* activity was significantly lower in Δ*lacZ*Δ*ompR* than in Δ*lacZ*, suggesting that OmpR increases type 3 fimbriae expression at the transcriptional level in response to hypertonic stresses.

![OmpR activates *mrkA* expression. **(A)** qRT-PCR analyses of the *mrkA* expression for WT, Δ*ompR*, Δ*ompR* (pACYC184), and Δ*ompR* (pOmpR) strains in LB broth with or without 400 mM NaCl. **(B)** β-galactosidase activities of *K. pneumoniae* CG43S3Δ*lacZ* and the isogenic strain (Δ*lacZ*Δ*ompR*) carrying the reporter plasmid pmrkAZ15 (P*~mrkA~*::*lacZ)* were determined using log-phase cultures grown in LB broth with or without 400 mM NaCl. The results are representative of three independent experiments. Error bars indicate standard deviations. ^∗∗^*P* \< 0.01 compared to the indicated group.](fmicb-09-02405-g002){#F2}

Phosphorylated OmpR Is Required for Increasing MrkA Expression
--------------------------------------------------------------

To test whether the effect of OmpR on *mrkA* transcription and protein production might require phosphorylation of OmpR at aspartate 55, a site-directed mutant with a single amino acid substitution of aspartate 55 to alanine (D55A), which prevents phosphorylation, was generated. As shown in **Figure [3A](#F3){ref-type="fig"}**, MrkA production was decreased in the *ompR*~D55A~ mutant than in the WT strain when grown in LB broth with 400 mM NaCl. Furthermore, *mrkA* mRNA levels were lower in the *ompR*~D55A~ mutant compared to the WT strain when grown in LB broth with 400 mM NaCl (**Figure [3B](#F3){ref-type="fig"}**). Similarly, lower *mrkA* promoter activity was observed in the OmpR~D55A~ mutant (**Figure [3C](#F3){ref-type="fig"}**). These results suggest that the phosphorylated form of OmpR is required for increasing type 3 fimbriae expression.

![Effect of phosphorylated OmpR on regulating MrkA expression in *K. pneumoniae*. *K. pneumoniae* CG43S3 WT and *ompR*~D55A~ strains was grown to mid-log phase at 37°C in LB broth with 400 mM NaCl to observe the type 3 fimbriae expression by **(A)** western blot analysis against MrkA, and **(B)** qRT-PCR analyses of *mrkA* gene expression. **(C)** β-galactosidase activities of *K. pneumoniae* CG43S3 Δ*lacZ* and the isogenic strains (Δ*lacZ*\_OmpR~D55A~) carrying the reporter plasmid pmrkAZ15 (P*~mrkA~*::*lacZ*) were determined using log-phase cultures grown in LB broth with 400 mM NaCl. The results are representative of three independent experiments. Error bars indicate standard deviations. ^∗∗^*P* \< 0.01 compared to the indicated group. The fold change of MrkA production calculated by Image J software is also shown.](fmicb-09-02405-g003){#F3}

OmpR-Mediated Regulation of Type 3 Fimbriae Expression Is Probably Indirect
---------------------------------------------------------------------------

To investigate the mechanism underlying OmpR regulation of *mrkA* transcription, the consensus sequence of the *E. coli* OmpR∼P binding site was used as a reference for analyzing the *mrkA* promoter sequence ([@B76]). However, no typical OmpR binding site was found upstream of *mrkA*. To further confirm the absence of OmpR∼P binding activity in P*~mrkA~*, the interaction between a recombinant OmpR::His~6~ protein phosphorylated by acetyl-phosphate and DNA fragments containing P*~mrkA~* and P*~ompF~* (positive control) were examined by EMSA. As shown in **Figure [4](#F4){ref-type="fig"}**, a DNA-protein-binding complex was observed following incubation of 1.3 μM phosphorylated OmpR::His~6~ and 10 ng P*~ompF~*. However, no binding activity was observed for the phosphorylated OmpR::His6 protein with P*~mrkA~* (**Figure [4](#F4){ref-type="fig"}**). These results indicate that OmpR activation of type 3 fimbriae expression may be indirect.

![Binding activity of phosphorylated OmpR::His~6~ with P*~ompF~* and P*~mrkA~*. Different concentrations of purified OmpR::His~6~ were incubated with 25 mM acetyl phosphate and 10 ng of the upstream regions of *ompF* and *mrkA*. Following incubation at room temperature for 20 min, the mixtures were analyzed on a 5% non-denaturing polyacrylamide gel. The gel was stained with SYBR Green I dye and photographed.](fmicb-09-02405-g004){#F4}

Regulatory Effect of OmpR on *mrkHIJ* Expression
------------------------------------------------

Previous studies have demonstrated that MrkHIJ play an important role in regulating type 3 fimbriae expression ([@B44]; [@B71]). To further examine whether MrkHIJ are involved in OmpR regulon, the mRNA levels of these genes were measured in the WT and Δ*ompR* strains grown in LB broth with or without 400 mM NaCl by qRT-PCR. In contrast to the lack of an apparent effect in the WT and Δ*ompR* strains in LB without NaCl, *mrkH*, *mrkI*, and *mrkJ* mRNA levels were markedly decreased in the Δ*ompR* strain in LB broth with 400 mM NaCl (**Figure [5](#F5){ref-type="fig"}**). In addition, a similar reduction was also observed in the *ompR*~D55A~ mutant. This indicates that the phosphorylated form of OmpR is required for increasing *mrkH*, *mrkI*, and *mrkJ* mRNA expression. However, no typical OmpR∼P binding site was found upstream of *mrkHI* and *mrkJ* and no binding activity was observed for the phosphorylated OmpR::His6 protein with P*~mrkHI~* and P*~mrkJ~* (data not shown), suggesting that OmpR∼P positive regulation of *mrkH*, *mrkI*, and *mrkJ* expression is indirect.

![Effect of OmpR on regulating *mrkH*, *mrkI*, and *mrkJ* expression. qRT-PCR analyses of the *mrkH*, *mrkI*, and *mrkJ* expressions for WT, Δ*ompR*, and *ompR*~D55A~ strains in LB broth with (solid bars) or without 400 mM NaCl (dot bars). The results are representative of three independent experiments. Error bars indicate standard deviations. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01 compared to the indicated group.](fmicb-09-02405-g005){#F5}

Effect of OmpR on Intracellular c-di-GMP Concentration, PDE Activity, and PDE-Related Genes Expression
------------------------------------------------------------------------------------------------------

Based on the previous study, the expression of type 3 fimbriae and MrkHI is c-di-GMP dependent ([@B65]). To further investigate whether OmpR affects the c-di-GMP production, thus increasing type 3 fimbriae and MrkHI expression, the intracellular concentration of c-di-GMP was measured in the WT and Δ*ompR* strains grown in LB broth with or without 400 mM NaCl. As shown in **Figure [6A](#F6){ref-type="fig"}**, the c-di-GMP concentration of *K. pneumoniae* decreased in LB with 400 mM NaCl. Furthermore, the c-di-GMP concentration was lower in the Δ*ompR* strain than in the WT strain in LB broth with 400 mM NaCl, while this effect was not observed in LB without NaCl. An apparent lower intracellular c-di-GMP concentration was also found in the *ompR*~D55A~ strain relative to the WT strain when grown in LB with 400 mM NaCl. These results indicate that OmpR∼P is required for increasing intracellular c-di-GMP production in *K. pneumoniae* under hypertonic conditions. In bacteria, intracellular c-di-GMP is degraded by PDEs ([@B58]; [@B19]). Therefore, we evaluated the *in vitro* PDE activity of crude extracts from the WT and Δ*ompR* strains grown in LB with or without 400 mM NaCl using a colorimetric assay. As shown in **Figure [6B](#F6){ref-type="fig"}**, the WT strain demonstrated a slightly higher PDE activity in LB with 400 mM NaCl. Furthermore, the PDE activity in the Δ*ompR* extract was higher than in the WT extract in LB with 400 mM NaCl, but not in LB without NaCl. In addition, the *ompR*~D55A~ mutant exhibited higher PDE activity in response to 400 mM NaCl compared to the WT strain. Therefore, we hypothesized that OmpR∼P can decrease PDE activity to further increase intracellular c-di-GMP concentrations, resulting in elevated type 3 fimbriae and *mrkHI* expression. Analysis of the upstream sequences of the c-di-GMP PDE related open reading frames (ORFs) in *K. pneumoniae* CG43, including *mrkJ* (D364_16630), D364_06025, *fimK* (D364_16730), D364_04060, D364_08130, D364_16830, *ylaB* (D364_02175), *yoaD* (D364_11845), *rtn* (D364_13295), and *yjcC* (D364_22720), did not reveal any typical OmpR∼P binding sites (data not shown). To further investigate the effect of OmpR∼P on the expression of these c-di-GMP PDE related ORFs, the mRNA expression of these ORFs was measured in the WT and *ompR*~D55A~ strains in response to 400 mM NaCl. As shown in **Figure [6C](#F6){ref-type="fig"}**, the mRNA levels of *fimK* and D364_16830 were increased, while the mRNA levels of D364_13295 and *yjcC* were decreased in the *ompR*~D55A~ strain. Therefore, *fimK* and D364_16830 may be involved in repression of PDE activity by OmpR∼P.

![Effect of phosphorylated OmpR on c-di-GMP concentration, PDE activity, and PDE-related genes expression. **(A)** c-di-GMP concentration of WT, Δ*ompR*, and *ompR*~D55A~ strains in LB broth with 400 mM NaCl (solid gray bars) or without (open white bars) was quantified by ELISA according to the manual (Wuhan EIAab Science). Relative percentage of c-di-GMP content was calculated by the c-di-GMP concentration of extracts is relative to that of WT strain. **(B)** The PDE activity of crude extracts of WT, Δ*ompR*, and *ompR*~D55A~ strains in LB broth with 400 mM NaCl (solid gray bars) or without (open white bars) was determined by using *bis*-pNPP as substrate and measuring the absorbance at OD410. Relative percentage of PDE activity was calculated by the OD410 of crude extracts is relative to that of WT strain. **(C)** qRT-PCR analyses of the PDE-related genes expression for WT and *ompR*~D55A~ strains in LB broth with 400 mM NaCl. The results are representative of three independent experiments. Error bars indicate standard deviations. ^∗∗^*P* \< 0.01 compared to the indicated group.](fmicb-09-02405-g006){#F6}

OmpR Increases Biofilm Amount Under Hypertonic Conditions
---------------------------------------------------------

Type 3 fimbriae are a major determinant modulating *K. pneumoniae* biofilm formation ([@B14]; [@B22]; [@B71]). To further investigate the role of OmpR in *K. pneumoniae* biofilm formation, the biofilm amount of WT and Δ*ompR* grown in LB broth with and without 400 mM NaCl was measured. As shown in **Figure [7](#F7){ref-type="fig"}**, biofilm amount was lower in Δ*ompR* than in the WT strain in LB broth with 400 mM NaCl, while no apparent effect was observed in LB broth without NaCl. Furthermore, introduction of the complementation plasmid, pompR, into the Δ*ompR* strain increased biofilm amount, compared to Δ*ompR* carrying the empty vector in LB broth supplemented with 400 mM NaCl. These results indicate that OmpR can increase biofilm amount in *K. pneumoniae* under hypertonic conditions. In addition, we evaluated biofilm amount in the *ompR*~D55A~ mutant grown LB broth supplemented with 400 mM NaCl; biofilm amount was decreased in the *ompR*~D55A~ strain compared to the WT strain, indicating that the phosphorylated form of OmpR increased biofilm amount in *K. pneumoniae* CG43S3 under hypertonic conditions.

![Effect of OmpR on biofilm formation. *K. pneumoniae* strains CG43S3 WT, Δ*ompR*, *ompR*~D55A~, Δ*ompR* (pACYC184), and Δ*ompR* (pOmpR) were grown at 37°C for 24 h in LB broth with 400 mM NaCl (solid gray bars) or without (open white bars), and bacterial biofilm formation was quantified as described in Materials and Methods. The results are representative of three independent experiments. Error bars indicate standard deviations. ^∗∗^*P* \< 0.01 compared to the indicated group.](fmicb-09-02405-g007){#F7}

Discussion
==========

OmpR/EnvZ is a well-known TCS in many species of *Enterobacteriaceae*, which regulates the expression of various virulence genes in response to osmotic stresses ([@B41]; [@B46]). However, the role of OmpR/EnvZ in *K. pneumoniae* pathogenesis remains largely unknown. In this study, we found that OmpR∼P activated type 3 fimbriae expression and biofilm formation under hypertonic conditions. Additionally, OmpR regulation of type 3 fimbriae expression appeared to involve the c-di-GMP signaling pathway. Our previous studies have also shown that transcription factors, such as Fur, cAMP-CRP, and IscR, coordinate c-di-GMP related proteins, MrkH, MrkI, and MrkJ, to regulate type 3 fimbriae expression in response to iron availability and exogenous glucose stimuli in *K. pneumoniae* ([@B71]; [@B36], [@B37]). These findings indicate that *K. pneumoniae* needs to orchestrate various signaling pathways in response to dynamic environmental cues in order to regulate the expression of virulence factors for successful infection.

In this study, we found that osmotic stress repressed type 3 fimbriae expression in *K. pneumoniae* CG43S3 (**Figure [1A](#F1){ref-type="fig"}**). In *E. coli*, transcriptional regulators, including CpxAR, RpoS, Lrp, and H-NS, have been demonstrated to play important roles in bacterial responses to osmotic stress ([@B33]; [@B12]; [@B17]; [@B18]; [@B50]). Of these regulators, H-NS has been shown to directly repress the expression of *mrkHIJ*, while activating the expression of *mrkA* ([@B3], [@B2]). It has also been demonstrated that increased osmolality can reduce the polymerization of H-NS tetramers and subsequently decrease the regulatory activity of H-NS ([@B60]). Thus, whether polymerization of H-NS in response to osmotic stress affects type 3 fimbriae expression in *K. pneumoniae* should be investigated in future studies. Furthermore, we noted that OmpR activated type 3 fimbriae expression under hypertonic conditions and that the phosphorylation status of OmpR played a crucial role in this regulation (**Figures [1](#F1){ref-type="fig"}**, **[3](#F3){ref-type="fig"}**). Intracellular OmpR∼P levels are tightly controlled by EnvZ, which exhibits high phosphatase activity and low kinase activity at low osmolality ([@B39]). Taken together, these findings suggest that the relatively high level of OmpR∼P present in response to hypertonic conditions can increase type 3 fimbriae expression in *K. pneumoniae*.

In *K. pneumoniae*, the type 1 and type 3 fimbrial gene clusters are physically linked and deletion of *mrkA* increases the production of FimA, the major subunit of type 1 fimbriae ([@B69]), implying that expression of these fimbriae is coordinately regulated. In *E. coli*, deletion of *ompR* increased type 1 fimbriae expression via the activation of *fimB* transcription ([@B53]). We also found that the mRNA levels of *fimA* and *fimB* were increased in the *K. pneumoniae* Δ*ompR* strain compared to the WT strain when grown in LB broth with 400 mM NaCl (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). This result shows that OmpR also decreases type 1 fimbriae expression in *K. pneumoniae*; further investigation is required to elucidate the underlying mechanism(s). To our knowledge, the gene clusters, *mrkABCDEF* and *mrkHIJ*, are highly conserved among *K. pneumniae* strains with about 99% amino acid identities, but are not found in other bacteria. Since we focused on the study of the OmpR regulation on the expression of *mrk* genes, which are not found in the genomes of *S.* Typhimurium, *S. flexneri*, *Y. pestis*, and *A. baumanni*, it is difficult to make a comparison.

High concentrations of c-di-GMP are linked to bacterial biofilm formation ([@B9]; [@B23]). In *K. pneumoniae*, intracellular c-di-GMP concentrations influence the regulatory activity of MrkH on type 3 fimbriae expression and bacterial biofilm amount ([@B70]; [@B74]). Our results might indicate that OmpR indirectly regulates the expression of *mrkHIJ* (**Figure [5](#F5){ref-type="fig"}**). Multiple genes encoding GGDEF- and EAL-domain containing proteins have been identified in the *K. pneumoniae* genome and their expression, in response to various environmental stimuli, may influence intracellular c-di-GMP concentrations ([@B16]; [@B25]). Although OmpR∼P has an apparent effect on modulating c-di-GMP concentration and the intracellular PDE activity, only a slight increase in the mRNA levels of *fimK* and D364_16830 was observed (**Figure [6](#F6){ref-type="fig"}**). Whether OmpR∼P affects the expression of *fimK* and D364_16830 to increase PDE activity, needs to be clarified. In addition, hybrid proteins with both GGDEF and EAL domains may exert dual activities or only single activity depending on various cellular conditions ([@B16]; [@B25]). Therefore, OmpR may also affect the expression of ORFs encoding hybrid proteins with both GGDEF and EAL domains, to modulate PDE activity; this possibility needs to be further investigated. In *E. coli*, OmpR∼P represses the expression of *bolA*, which is responsible for cell growth and division ([@B73]). Deletion of *bolA* increases intracellular c-di-GMP concentrations and biofilm formation in *E. coli* ([@B42]), suggesting that OmpR∼P represses *bolA* expression to modulate intracellular c-di-GMP concentrations. We identified a *bolA* homolog (D364_02025) in the genome of *K. pneumoniae* CG43, which shared 91.3% amino acid sequence identity with the *E. coli* protein. However, determining whether OmpR regulates the expression of *bolA* to affect intracellular c-di-GMP concentrations, type 3 fimbriae production, and biofilm formation in *K. pneumoniae* will require further investigation.

Type 3 fimbriae expression is thought to play a crucial role in *K. pneumoniae* biofilm formation; thus, we hypothesized that bacterial biofilm formation is affected by osmotic stimuli. However, no apparent effect on biofilm formation was observed when *K. pneumoniae* was grown in LB broth with or without 400 mM NaCl (**Figure [7](#F7){ref-type="fig"}**). In addition to type 3 fimbriae, multiple factors have been reported to affect *K. pneumoniae* biofilm formation such as CPS, LPS, quorum-sensing systems, and antibiotic resistance ([@B5], [@B4]; [@B8]; [@B1]; [@B27]; [@B68]). We also found that CPS levels were increased under hypertonic conditions (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**). As the thick capsule of *K. pneumoniae* impedes the assembly of type 3 fimbriae ([@B56]), the decrease in type 3 fimbriae under hypertonic conditions may also be due to an increase in CPS levels. However, no apparent difference in CPS amount was observed between WT and Δ*ompR* strains grown under hypertonic conditions (data not shown), implying the involvement of other regulator(s). In *E. coli*, OmpR regulates the expression of the porins OmpF and OmpC in response to osmotic stress ([@B41]). Furthermore, the deletion of *ompF* can increase bacterial biofilm formation ([@B75]). *K. pneumoniae* possess two classical porins, OmpK35 and OmpK36, which are homologs of *E. coli* OmpF and OmpC, respectively ([@B63]). In *K. pneumoniae*, biofilm formation is highly related to antibiotic resistance ([@B68]), which is affected by the expression of porins and efflux pumps (e.g., AcrAB) ([@B7]; [@B48]). Taken together, these findings suggest that OmpR∼P coordinately regulates the expression of OmpK35, OmpK36, and type 3 fimbriae to mediate *K. pneumoniae* biofilm formation. This possibility needs to be further investigated.

In this study, we provide evidence that OmpR∼P participates in the regulation of type 3 fimbriae and *mrkHIJ* expression, c-di-GMP concentration, and biofilm formation in response to osmotic stress, which may play an important role during successful infection.
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